These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10460311)

  • 1. A comparison of the effects of amphetamine and low doses of apomorphine on operant force production, inter-response times and response duration in rat.
    Liu X; Strecker RE; Brener J
    Psychopharmacology (Berl); 1999 Aug; 145(4):351-9. PubMed ID: 10460311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low doses of apomorphine suppress operant motor performance in rats.
    Liu X; Strecker RE; Brener JM
    Pharmacol Biochem Behav; 1996 Feb; 53(2):335-40. PubMed ID: 8808141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine depletion in nucleus accumbens influences locomotion but not force and timing of operant responding.
    Liu X; Strecker RE; Brener J
    Pharmacol Biochem Behav; 1998 Mar; 59(3):737-45. PubMed ID: 9512080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine motor control in rats is disrupted by delta-9-tetrahydrocannabinol.
    Mclaughlin PJ; Delevan CE; Carnicom S; Robinson JK; Brener J
    Pharmacol Biochem Behav; 2000 Aug; 66(4):803-9. PubMed ID: 10973519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
    Jeziorski M; White FJ
    Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed-ratio discrimination training as replacement therapy in Parkinson's disease: studies in a 6-hydroxydopamine-treated rat model.
    Van Keuren KR; Stodgell CJ; Schroeder SR; Tessel RE
    Brain Res; 1998 Jan; 780(1):56-66. PubMed ID: 9473587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine.
    Depoortere R; Perrault G; Sanger DJ
    Psychopharmacology (Berl); 1996 Apr; 124(3):231-40. PubMed ID: 8740044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The reduction of water intake in rats caused by a low dose of apomorphine is unaltered by alpha-methyl-p-tyrosine: are autoreceptors not involved?
    Ljungberg T; Ståhle L
    J Neural Transm Gen Sect; 1989; 78(3):265-9. PubMed ID: 2803702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential stimulation of D1 or D2 receptors disrupts food-rewarded operant responding in rats.
    Hoffman DC; Beninger RJ
    Pharmacol Biochem Behav; 1989 Dec; 34(4):923-5. PubMed ID: 2576145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor antagonists reverse amphetamine-induced behavioral alteration on a differential reinforcement for low-rate (DRL) operant task in the rat.
    Cheng RK; Liao RM
    Chin J Physiol; 2007 Apr; 50(2):77-88. PubMed ID: 17608145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic D-amphetamine treatment.
    White FJ; Wang RY
    Brain Res; 1984 Sep; 309(2):283-92. PubMed ID: 6478223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response changes after repeated low apomorphine: dopamine autoreceptor desensitization or learning?
    Nickolson VJ; van Riezen H; van Delft AM
    Psychopharmacology (Berl); 1984; 83(2):188-93. PubMed ID: 6431472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats.
    Geyer MA; Russo PV; Segal DS; Kuczenski R
    Pharmacol Biochem Behav; 1987 Nov; 28(3):393-9. PubMed ID: 3685075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effects of amphetamine, apomorphine and white noise on response switching in the rat.
    Evenden JL; Doggett SJ
    Psychopharmacology (Berl); 1989; 97(2):238-42. PubMed ID: 2498934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postnatal lead exposure induces supersensitivity to the stimulus properties of a D2-D3 agonist.
    Cory-Slechta DA; Pokora MJ; Widzowski DV
    Brain Res; 1992 Dec; 598(1-2):162-72. PubMed ID: 1362517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological analysis of the apomorphine discriminative stimulus in rhesus monkeys.
    Woolverton WL; Kamien JB; Goldberg LI
    J Pharmacol Exp Ther; 1987 Apr; 241(1):213-7. PubMed ID: 3553538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
    Arnerić SP; Long JP; Williams M; Goodale DB; Mott J; Lakoski JM; Gebhart GF
    J Pharmacol Exp Ther; 1983 Jan; 224(1):161-70. PubMed ID: 6401334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of d-amphetamine on the differential reinforcement of low-rate (DRL) schedule behavior in the rat: comparison with selective dopamine receptor antagonists.
    Liao RM; Cheng RK
    Chin J Physiol; 2005 Mar; 48(1):41-50. PubMed ID: 15973966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latent inhibition is unaffected by direct dopamine agonists.
    Feldon J; Shofel A; Weiner I
    Pharmacol Biochem Behav; 1991 Feb; 38(2):309-14. PubMed ID: 1676170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
    Olds ME
    Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.